Lanatoside C: Difference between revisions

Lanatoside C
Clinical data
ATC code	C01AA06 (WHO) ;
Identifiers
	IUPAC name [6-[6-[6-[ [12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl] acetate;
CAS Number	17575-22-3;
PubChem CID	3879;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C49H76O20
Molar mass	985.116 g/mol

Revision as of 16:46, 9 August 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Lanatoside C (or isolanid) is a cardiac glycoside.

Revision as of 18:12, 27 September 2011 (view source) WikiBot (talk \| contribs) m (Protected "Lanatoside C": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))		Revision as of 16:46, 9 August 2012 (view source) WikiBot (talk \| contribs) m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) Newer edit →
Line 27:		Line 27:
	{{CMG}}		{{CMG}}

	~~{{Editor Join}}~~

Clinical data

ATC code	C01AA06 (WHO)
Identifiers
IUPAC name [6-[6-[6-[ [12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl] acetate
CAS Number	17575-22-3
PubChem CID	3879
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₄₉H₇₆O₂₀
Molar mass	985.116 g/mol